Join the New Zealand Business Roundtable in China (NZBRiC) for our Q1 Dairy Industry Forum on March 4 – the first Industry Forum of the year!
This forum will explore key strategies for navigating market volatility and unlocking new growth opportunities in health markets, driven by healthy aging and GLP-1 medications like Ozempic.
The session will feature two expert presentations:
- Matthew Lin, Senior Risk & Commercial Solutions Manager at Fonterra, will discuss how to manage dairy price volatility with futures contracts and explore the opportunities emerging in the healthy aging market.
- Madison Stratton, Business Development Manager at Tatua China, will delve into the growing demand for dairy ingredients driven by the rise of GLP-1 medications, offering fresh insights for dairy businesses to seize this opportunity.
Daniel Young, President of Tatua China and NZBRiC Dairy Industry Chair, will lead the session and guide an open discussion and Q&A, helping to synthesise key insights from both speakers and engage attendees in exploring practical takeaways together.
After the forum, we invite attendees to stay for networking and drinks at a nearby venue.
📥 If you are not a member and would like to attend this event, please contact us via email at information@nzbric.com.
Agenda:
3:00pm: Registration
3:15pm: Forum begins & introduction from Acting Dairy Industry Chair Meng Chea
3:20pm: Matthew Lin –Stability & Growth: Managing Dairy Price Volatility with Futures Contracts; New Opportunities in Healthy Aging.
3:55pm: Madison Stratton –Evolving Needs for Dairy Ingredients with the Rising Use of GLP-1 Medications
4:15pm: Roundtable discussion and Q&A
5:00pm: Walk down to a local venue for networking drinks
